Papers - MARUYAMA, Shoichi
-
Association of Estimated Glomerular Filtration Rate and Proteinuria With Lipid-Rich Plaque in Coronary Artery Disease. Reviewed
Shimbo Y, Suzuki S, Ishii H, Shibata Y, Tatami Y, Harata S, Osugi N, Ota T, Tanaka A, Shibata K, Mizukoshi T, Yasuda Y, Maruyama S, Murohara T.
Circ J Vol. 79 ( 10 ) page： 2263 - 2270 2015.9
-
Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Reviewed
Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S.
Clin Exp Nephrol Vol. 19 ( 4 ) page： 653 - 660 2015.8
-
Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. Reviewed
Sato Y, Sato W, Maruyama S, Wilcox CS, Falck JR, Masuda T, Kosugi T, Kojima H, Maeda K, Furuhashi K, Ando M, Imai E, Matsuo S, Kadomatsu K.
J Am Soc Nephrol Vol. 26 ( 8 ) page： 1806 - 1815 2015.8
-
CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint. Reviewed
Kosugi T1, Maeda K1, Sato W1, Maruyama S1, Kadomatsu K2.
Nephrol Dial Transplant Vol. 30 ( 7 ) page： 1097 - 1103 2015.7
-
Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy. Reviewed
Sei Y, Mizuno M, Suzuki Y, Imai M, Higashide K, Harris CL, Sakata F, Iguchi D, Fujiwara M, Kodera Y, Maruyama S, Matsuo S, Ito Y.
Mol Immunol Vol. 65 ( 2 ) page： 302 - 309 2015.6
-
Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients. Reviewed
Takayama Y, Yasuda Y, Suzuki S, Shibata Y, Tatami Y, Shibata K, Niwa M, Sawai A, Morimoto R, Kato S, Ishii H, Maruyama S, Murohara T.
Heart Vessels Vol. 31 ( 7 ) page： 1030 - 1037 2015.6
-
Longitudinal Study of the Decline in Renal Function in Healthy Subjects. Reviewed
Baba M, Shimbo T, Horio M, Ando M, Yasuda Y, Komatsu Y, Masuda K, Matsuo S, Maruyama S.
PLoS One Vol. 10 ( 6 ) page： e0129036 2015.6
-
Clinical impact of kidney function on presepsin levels. Reviewed
Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, Tsuboi N, Matsuo S, Maruyama S.
PLoS One Vol. 10 ( 6 ) page： e0129159 2015.6
-
Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial). Reviewed
Imai E, Maruyama S, Nangaku M, Hirakata H, Hayashi T, Narita I, Kono H, Nakatani E, Morita S, Tsubakihara Y, Akizawa T.
Clin Exp Nephrol Vol. 20 ( 1 ) page： 71 - 76 2015.6
-
CD147/Basigin limits lupus nephritis and TH 17 cell differentiation by inhibiting the IL-6/STAT3 pathway. Reviewed
Maeda K, Kosugi T, Sato W, Kojima H, Sato Y, Kamimura D, Kato N, Tsuboi N, Yuzawa Y, Matsuo S, Murakami M, Maruyama S, Kadomatsu K.
Arthritis Rheum Vol. 67 ( 8 ) page： 2185 - 2195 2015.5
-
Functional Difference Between Membrane-Bound and Soluble Human Thrombomodulin. Reviewed
Miwa Y, Yazaki S, Iwamoto M, Suzuki S, Iwasaki K, Haneda M, Yamamoto K, Maruyama S, Onishi A, Kobayashi T.
Transplantation Vol. 99 ( 4 ) page： 702 - 709 2015.4
-
Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury. Reviewed
Terabayashi T, Ito Y, Mizuno M, Suzuki Y, Kinashi H, Sakata F, Tomita T, Iguchi D, Tawada M, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y.
Lab Invest Vol. 95 ( 9 ) page： 1029 - 1043 2015.4
-
Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1. Reviewed
Shibata K, Yasuda Y, Kobayashi R, Ando Y, Shimokata T, Kamiya H, Hayashi M, Maruyama S, Matsuo S, Nakao M, Tsuchiya T, Teramachi H.
Clin Exp Nephrol Vol. 19 ( 6 ) page： 1107 - 1113 2015.4
-
The efficacy of tolvaptan as a diuretic for chronic kidney disease patients. Reviewed
Tanaka A, Katsuno T, Ozaki T, Sakata F, Kato N, Suzuki Y, Kosugi T, Kato S, Tsuboi N, Sato W, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.
Acta Cardiol Vol. 70 ( 2 ) page： 217 - 223 2015.4
-
Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial. Reviewed
Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S.
Clin Exp Nephrol Vol. 19 ( 6 ) page： 1098 - 1106 2015.3
-
Identification of an Interaction between VWF rs7965413 and Platelet Count as a Novel Risk Marker for Metabolic Syndrome: An Extensive Search of Candidate Polymorphisms in a Case-Control Study. Reviewed
Nakatochi M, Ushida Y, Yasuda Y, Yoshida Y, Kawai S, Kato R, Nakashima T, Iwata M, Kuwatsuka Y, Ando M, Hamajima N, Kondo T, Oda H, Hayashi M, Kato S, Yamaguchi M, Maruyama S, Matsuo S, Honda H.
PLoS One Vol. 10 ( 2 ) page： e0117591 2015
-
A ray of light in the dark: alternative approaches to the assessment and treatment of ischemic nephropathy. Reviewed
Tsuboi N, Maruyama S, Matsuo S, Imai E.
Nephrol Dial Transplant Vol. 29 ( 2 ) page： 228 - 231 2014
-
Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency. Reviewed
Shi Y1, Tsuboi N2, Furuhashi K3, Du Q1, Horinouchi A1, Maeda K1, Kosugi T1, Matsuo S1, Maruyama S1.
J Immunol Vol. 193 ( 10 ) page： 5129 - 5139 2014
-
CD147/basigin reflects renal dysfunction in patients with acute kidney injury. Reviewed
Nagaya H1, Kosugi T, Maeda-Hori M, Maeda K, Sato Y, Kojima H, Hayashi H, Kato N, Ishimoto T, Sato W, Yuzawa Y, Matsuo S, Kadomatsu K, Maruyama S.
Clin Exp Nephrol Vol. 18 ( 5 ) page： 746 - 754 2014
-
Smoking is a risk factor for the progression of idiopathic membranous nephropathy. Reviewed
Yamaguchi M1, Ando M2, Yamamoto R3, Akiyama S1, Kato S1, Katsuno T1, Kosugi T1, Sato W1, Tsuboi N1, Yasuda Y1, Mizuno M1, Ito Y1, Matsuo S1, Maruyama S1.
PLoS One Vol. 9 ( 6 ) page： e100835 2014